Профілактична заміна кореня аорти в пацієнтів із синдромом Марфана при виконанні пластики мітрального клапана

A. Kalangos, S.M. Cherian, J. Jolou, J.-C. Pache, H. Muller, P.O. Myers, M. Cikirikcioglu

Література

1. Aalberts JJ, Waterbolk TW, van Tintelen JP, et al. Prophylactic aortic root surgery in patients with Marfan syndrome: 10 years' experience with a protocol based on body surface area. Eur J Cardiothorac Surg. 2008;34:589-594.
2. Alexiou C, Langley S.M, Charlesworth P, et al. Aortic root replacement in patients with Marfan's syndrome: the Southampton experience. Ann. Thorac. Surg. 2001;72:1502-1507.
3. Cañadas V, Vilacosta I, Bruna I, Fuster V. Nat Rev. Cardiol. 2010;7:256-265 (266-276).
4. Carpentier A. Cardiac valve surgery – the «French correction». J. Thorac. Cardiovasc. Surg. 1983;86:323-337.
5. David TE, Armstrong S, Maganti M, et al. Long-term results of aortic valve-sparing operations in patients with Marfan syndrome. J Thorac Cardiovasc Surg. 2009;138:859-864.
6. Davies RR, Gallo A, Coady MA, et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg 2006;81:169-177.
7. De Paepe A, Devereux RB, Dietz HC, et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996;24:417-426.
8. Fleischer KJ, Nousari HC, Anhalt GJ, et al. Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan’s syndrome. Ann Thorac Surg. 1997;63:1012-1017.
9. Fornes P, Heudes D, Fuzellier JF, et al. Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. Cardiovasc Pathol 1999;8:81-92.
10. Gillinov AM, Hulyalkar A, Cameron DE, et al. Mitral valve operation in patients with the Marfan syndrome. J Thorac Cardiovasc Surg. 1994;107:724-731.
11. Gott VL, Cameron DE, Alejo DE, et al. Aortic root replacement in 271 Marfan patients: a 24-year experience. Ann Thorac Surg. 2002;73:438-443.
12. Gott VL, Greene PS, Alejo DE, et al. Replacement of the aortic root in patients with Marfan's syndrome. New Engl J Med. 1999;29:1307-1313.
13. Hirata K, Triposkiadis F, Sparks E, et al. The Marfan syndrome: cardiovascular physical findings and diagnostic correlates. Am Heart J. 1992;123:743-752.
14. Kalangos A, Sierra J, Vala D, et al. Annuloplasty for valve repair with a new biodegradable ring: an experimental study. J Heart Valve Dis. 2006;15:783-790.
15. Keane MG, Pyeritz RE. Medical management of Marfan syndrome. Circulation. 2008;27:2802-2813.
16. Konstantinov IE, Jalali H. Total chordal augmentation in a child with Marfan syndrome and severe mitral insufficiency. Tex Heart Inst. J. 2007;34:423-424.
17. Legget ME, Unger TA, O'Sullivan CK, et al. Aortic root complications in Marfan's syndrome: identification of a lower risk group. Heart. 1996;75:389-395.
18. Meijboom LJ, Timmermans J, Zwinderman AH, et al. Aortic root growth in men and women with the Marfan's syndrome. Am. J. Cardiol. 2005;15:1441-1444.
19. Miller DC. Valve-sparing aortic root replacement in patients with the Marfan syndrome. J Thorac Cardiovasc Surg. 2003;125. P. 773-778.
20. Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg.1996;62:932-935.
21. Morganroth J, Jones RH, Chen CC, et al. Two-dimensional echocardiography in mitral, aortic and tricuspid valve prolapsed. Am J Cardiol. 1986;46:1164.
22. Murdoch JL, Walker BA, Halpern BL, et al. Life expectancy and causes of death in the Marfan syndrome. New Engl. J. Med. 1972;13:804-808.
23. Pereira L, Andrikopoulos K, Tian J, et al. Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat. Genet. 1997;17:218-222.
24. Pyeritz RE, McKusick VA. The Marfan syndrome: diagnosis and management. New Engl J Med. 1979;5. P. 772-777.
25. Pyeritz RE, Wappel MA. Mitral valve dysfunction in the Marfan syndrome. Clinical and echocardiographic study of prevalence and natural history. Am J Med. 1983;74:797-807.
26. Roman MJ, Devereux RB, Kramer-Fox R, Spitzer M.C. Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan syndrome. Am J Cardiol. 1989;1:317-321.
27. Silverman NH, Gerlis LM, Horowitz ES, et al. Pathologic elucidation of the echocardiographic features of Ebstein's malformation of the morphologically tricuspid valve in discordant atrioventricular connections. Am J Cardiol. 1995;15. P. 1277-1283.
28. Smith JA, Fann JI, Miller DC, et al. Surgical management of aortic dissection in patients with the Marfan syndrome. Circulation. 1994;90:II235-242.
29. Svensson LG, Blackstone EH, Feng J, et al. Are Marfan syndrome and marfanoid patients distinguishable on long-term follow-up? Ann Thorac Surg. 2007;83:1067-1074.
30. Svensson LG, Crawford ES, Coselli JS, et al. Impact of cardiovascular operation on survival in the Marfan patient. Circulation. 1989;80:I233-242.
31. Trimarchi S, Nienaber CA, Rampoldi V, et al. International Registry of Acute Aortic Dissection Investigators: Contemporary results of surgery in acute type A aortic dissection: The International Registry of Acute Aortic Dissection experience. J Thorac Cardiovasc Surg. 2005;129:112-122.
32. Van Karnebeek CD, Naeff MS, Mulder BJ, et al. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child. 2001;84:129-137.
33. Working group “Congenitale cardiologie bij volwassenen” of the Dutch Society of Cardiology. Adult congenital heart disease in the Netherlands: Guidelines 2000. The Hague: The Netherlands Heart Foundation. 2000.

Огляд сучасних рекомендацій щодо ведення пацієнтів з аортальним стенозом

М.Т. Ватутін, Є.В. Єщенко, Ю.П. Гриценко, О.І. Століка

Література

1. Vatutin NT. Heart defects. Donetsk: Kashtan, 2002. 266 p. (in Russ.).
2. Karpova NYu, Rashid MA, Kazakova TV, Shostak NA. Aortic stenosis. Russ Med J. 2014;2:162-166. (in Russ.).
3. Pavliuk VI, Zharinov OJ, Ponich NV. Aortic stenosis. Cardiac Surgery and Interventional Cardiology. 2014;2(7):9-16. (in Ukr.).
4. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):2438–2488.
5. Linke A,Wenaweser P,Gerckens U, et al. Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study. Eur Heart J. 2014;35(38):2672–2684.

Мітральний стеноз

В.І. Павлюк

Література 

1. Pavlyuk VI. Practical echocardiography. Ed. by О.J. Zharinov. Lviv: Medycina svitu, 2014. 156 p. (in Ukr.).
2. Armstrong WF, Ryan T, Feigenbaum H. Feigenbaum’s Echocardiography. Lippincott Williams & Wilkins, 2010. 785 p.
3. Arora R, Kalra GS, Singh S, et al. Percutaneous transvenous mitral commissurotomy: immediate and long-term follow-up results. Catheter Cardiovasc. Interv. 2002;55:450-456.
4. Baumgartner H, Hung J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J. Am. Soc. Echocardiogr. 2009;22:1-23.
5. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J. Am. Coll. Cardiol. 2006;48:e1-148.
6. Carabello BA. Modern management of mitral stenosis. Circulation. 2005;112:432-437.
7. Carroll JD, Feldman T. Percutaneous mitral balloon valvotomy and the new demographics of mitral stenosis. JAMA. 1993;270:1731-1736.
8. Chandrashekhar Y. Secondary prevention in rheumatic fever and rheumatic heart disease: theory, practice and meta-analysis of available trials. A textbook of rheumatic fever / Eds. by Narula J, Virmani R, Reddy KS, Tandon RK. Washington, DC: Armed Forces Institute Press, 1999:299-342.
9. Chandrashekhar Y, et al. Mitral stenosis. Lancet. 2009;374:1271-1283.
10. Golbasi Z, Ucar O, Keles T, et al. Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation. Eur J Heart Fail. 2002;4:593-595.
11. Hu CL, Jiang H, Tang QZ, et al. Comparison of rate control and rhythm control in patients with atrial fibrillation after percutaneous mitral balloon valvotomy: a randomised controlled study. Heart. 2006;92:1096-1101.
12. Inoue K, Owaki T, Nakamura T, et al. Clinical application of transvenous mitral commissurotomy by a new balloon Catheter. J Thorac Cardiovasc Surg. 1984;87:394-402.
13. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J. 2003;13:1231-1243.
14. Iung B, Cormier B, Ducimetiere P, et al. Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. Circulation. 1996;94:2124-2130.
15. Iung B, Gohlke-Barwolf C, Tornos P, et al. Recommendations in the management of the asymptomatic patient with valvular heart disease. Eur Heart J. 2002;23:1253-1266.
16. Iung B, Nicoud-Houel A, Fondard O, et al. Temporal trends in percutaneous mitral commissurotomy over a 15-year period. Eur Heart J. 2004;25:701-707.
17. Kawanishi DT, Kotlewski A, McKay CR, et al. The relative value of clinical examination, echocardiography with doppler and cardiac catheterization with angiography in the evaluation of mitral valve disease. Surgery for heart valve disease / Ed. E. Bodnar. London: ICR Publishers, 1990:73-78.
18. Labovitz AJ, Nelson JG, Windhorst DM, et al. Frequency of mitral valve dysfunction from mitral anular calcium as detected by Doppler echocardiography. Am J Cardiol. 1985;55:133.
19. Li M, Dery JP, Dumesnil JG, et al. Usefulness of measuring net atrioventricular compliance by Doppler echocardiography in patients with mitral stenosis. Am J Cardiol. 2005;96:432-435.
20. Maganti K, et al. Valvular heart disease: diagnosis and management. Mayo Clin Proc. 2010;85:483-500.
21. Magne J, Mathieu P, Dumesnil JG, et al. Impact of prosthesis patient mismatch in survival after mitral replacement. Circulation. 2007;115:1417-1425.
22. Mahoney PD, Loh E, Blitz LR, et al. Hemodynamic effects of inhaled nitric oxide in women with mitral stenosis and pulmonary hypertension. Am. J. Cardiology. 2001;87:188-192.
23. Matsuyama K, Matsumoto M, Sugita T, et al. Predictors of residual tricuspid regurgitation after mitral valve surgery. Ann Thorac Surg. 2003;75:1826-1828.
24. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005-1011.
25. Padmavati S. Rheumatic fever and rheumatic heart disease in India at the turn of the century. Indian Heart J. 2001;53:35-37.
26. Rapp AH, Cigarroa JE, Lange RA, et al. Hemodynamic characteristics and procedural outcome of patients with mitral stenosis and a depressed cardiac output. Am J Cardiol. 2001;88:1212-1213.
27. Roberts WC, Perloff JK. Mitral valvular disease a clinicopathologic survey of the conditions causing the mitral valve to function аbnormally. Ann Intern Med. 1972;77:939-975.
28. Sagie A, Schwammenthal E, Palacios IF, et al. Significant tricuspid regurgitation does not resolve after percutaneous balloon mitral valvotomy. J. Thorac Cardiovasc Surg. 1994;108:727-735.
29. Serraf A, Zoghbi J, Belli E, et al. Congenital mitral stenosis with or without associated defects: an evolving surgical strategy. Circulation. 2000;102:166-171.
30. Song JK, Kang DH, Lee WE, et al. Factors determining the exercise capacity in mitral stenosis. Am J Cardiol. 1996;78:1060-1062.
31. Song H, Kang DH, Kim JH, et al. Percutaneous mitral valvuloplasty versus surgical treatment in mitral stenosis with severe tricuspid regurgitation. Circulation. 2007;116(Suppl):I246-250.
32. Tamai J, Yoshioka T, Yasuda S, et al. Increase in peak oxygen uptake by restoration of atrial contraction in patients after percutaneous transvenous mitral commissurotomy. J Heart Valve Dis. 1993;2:623-628.
33. Vora A, Karnad D, Goyal V, et al. Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study. Indian Heart J. 2004;56:110-116.
34. Yamamoto K, Ikeda U, Mito H, et al. Endothelin production in pulmonary circulation of patients with mitral stenosis. Circulation. 1994;89:2093-2098.

Діагностика атріовентрикулярних блокад. Показання до кардіостимуляції 

О.Й. Жарінов, В.О. Куць, Н.О. Мохначова, О.М. Грицай

Література

1. Zharinov OJ, Kuts VO, Verezhnikova GP, Serov OD. Workshop on electrocardiography. Lviv, 2014. 268 p. (in Ukr.).
2. Zharinov OJ, Kuts VO, Nesukay VA, Vershigora AV. Basics of electrocardiography. Lviv: Medycina svitu, 2013. 130 p. (in Ukr.).
3. Grishkin YuN. Differential diagnosis of arrhythmias. St. Petersburg: Foliant, 2000. 480 p. (in Russ.).
4. Kechker MI. Electrocardiographic findings and a brief description of ECG changes. Мoskva: Оverlit, 1993. 96 p. (in Russ.).
5. Kushakovsky MS. Cardiac arrhythmias. St. Petersburg: Foliant, 2004. 668 с.
6. Essential cardiology. Principles and practice. Ed. by Rosendorff C. Lviv: Medycina svitu, 2007. 1037 p. (in Russ.).
7. Treshkur TV, Berngard ER. Atrioventricular blockades. Clinic, diagnosis, indications for electrocardiotherapy. St. Petersburg, Мoskva, 2009. 176 p. (in Russ.).
8. Khan MG. Fast ECG analysis. St. Petersburg, Мoskva: Nevskii dialekt, Binom, 1999. 286 p. (in Russ.).
9. Surawicz B, Knilans TK. Chou’s electrocardiography in clinical practice. 5th ed. Saunders, 2001. 709 p.
10. The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). 2013 ESC Guidelines on cardiac pacing and resynchchronization therapy. Eur. Heart J. 2013;34:2281-2329.
11. The Task Force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur. Heart J. 2011;32:3147-3197.
12. Toff WD, Camm AJ, Skehan JD. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. New Engl. J. Med. 2005;353:145-155.

Альманах-2014: візуалізація серця і судин

S. Nakatani 

Література

1. Aldrovandi A, Maffei E, Palumbo A, et al. Prognostic value of computed tomography coronary angiography in patients with suspected coronary artery disease: a 24-month follow-up study. Eur Radiol. 2009;19:1653-1660.
2. Bamberg F, Klotz E, Flohr T, et al. Dynamic myocardial stress perfusion imaging using fast dual source CT with alternating table positions: initial experience. Eur Radiol. 2010;20:1168-1173.
3. Bellavia D, Pellikka PA, Abraham TP, et al. Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography. Am J Cardiol. 2008;101:1039-1045.
4. Bezerra HG, Costa MA, Guagliumi G, et al. Intracoronary optical coherence tomography: a comprehensive review. Clinical and research applications. J Am Coll Cardiol Intv. 2009;2:1035-1046.
5. Brix G, Nekolla EA, Borowski M, et al. Radiation risk and protection of patients in clinical SPECT/CT. Eur J Nucl Med Mol Imaging. 2014;41(suppl 1):S125-136.
6. Budoff MJ, Dowe D, Jollis JG, et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiogaphy of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol. 2008;52:1724-1732.
7. Bull S, White SK, Piechnik SK, et al. Human non-contrast T1values and correlation with histology in diffuse fibrosis. Heart. 2013;99:932-937.
8. Cho GY, Marwick TH, Kim HS, et al. Global 2-dimensional strain as a new prognosticator in patients with heart failure. J Am Coll Cardiol. 2009;54:618-624.
9. Choi JH, Min JK, Labounty TM, et al. Intracoronary transluminal attenuation gradient in coronary CT angiography for determining coronary artery stenosis. JACC Cardiovasc Imaging. 2011;4:1149-1157.
10. Ersbøll M, Valeur N, Mogensen UM, et al. Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction. J Am Coll Cardiol. 2013;61:2365-2373.
11. Fairbairn TA, Steadman CD, Mather AN, et al. Assessment of valve haemodynamics, reverse ventricular remodeling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study. Heart. 2013;99:1185-1191.
12. George RT, Jerosch-Herold M, Silva C, et al. Quantification of myocardial perfusion using dynamic 64-detector computed tomography. Invest Radiol. 2007;42:815-822.
13. Greif M, von Ziegler F, Bamberg F.et al. CT stress perfusion imaging for detection of haemodynamically relevant coronary stenosis as defined by FFR. Heart. 2013;99:1004-1011.
14. Guan J, Mishra S, Falk R.H, et al. Current perspectives on cardiac amyloidosis. Am J Physiol Heart Circ Physiol. 2012;302:H544-552.
15. Hachamovitch R, Rozanski A, Shaw LJ, et al. Impact of ischaemia and scar on the therapeutic benefit from myocardial revascularization vs. medical therapy among patients understanding stress-rest myocardial perfusion scintigraphy. Eur Heart J. 2011;32:1012-1024.
16. Hadamitzky M, Freissmuth B, Meyer T, et al. Prognostic value of coronary computed tomographic angiography for prediction of cardiac events in patients with suspected coronary artery disease. JACC Cardiovasc Imaging. 2009;2:404-411.
17. Jacobson AE, Senior R, Cerqueira MD, et al. Myocardial iodin-123 meta-iodobenzylguanidine imaging and cardiac events in chronic heart failure. Results of the progressive ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study. J Am Coll Cardiol. 2010;55:2212-2221.
18. Jang SJ, Kim MS, Park HJ, et al. Impact of heart failure with normal ejection fraction on the occurrence of ischaemic stroke in patients with atrial fibrillation. Heart. 2013;99:17-21.
19. Kim HJ, Vignon-Clementel IE, Coogan JS, et al. Patient-specific modeling of blood flow and pressure in human coronary arteries. Ann Biomed Eng. 2010;38:3195-3209.
20. Kim KJ, Choi SI, Lee MS, et al. The prevalence and characteristics of coronary atherosclerosis in asymptomatic subjects classified as low risk based on traditional risk stratification algorithm: assessment with coronary CT angiography. Heart. 2013;99:1113-1117.
21. Koyama J, Falk RH. Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging. 2010;3:333-342.
22. Kusunose K, Yamada H, Nishio S, et al. Index-beat assessment of left ventricular systolic and diastolic function during atrial fibrillation using myocardial strain and strain rate. J Am Soc Echocardiogr. 2012;25:953-959.
23. Kwong RY, Farzaneh-Far A. Measuring myocardial scar by CMR. JACC Cardiovasc Imaging. 2011;4:157-160.
24. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
25. Lee CS, Lin TH, Hsu PC, et al. Measuring left ventricular peak longitudinal systolic strain from a single beat in atrial fibrillation: validation of the index beat method. J Am Soc Echocardiogr. 2012;25:945-952.
26. Marshall A, Cheetham A, George RS, et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention. Heart. 2012;98:1359-1365.
27. Meijboom WB, Meijs MF, Schuijf JD, et al. Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study. J Am Coll Cardiol. 2008;52:2135-2144.
28. Messroghli DR, Niendorf T, Schultz-Menger J, et al. T1mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson. 2003;5:353-359.
29. Mewton N, Liu CY, Croisille P, et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol. 2011;57:891-903.
30. Miller JM, Rochitte CE, Dewey M, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008;359:2324-2336.
31. Miller TD, Hodge DO, Christian TF, et al. Effects of adjustment for referral bias on the sensitivity and specificity of single photon emission computed tomography for the diagnosis of coronary artery disease. Am J Med. 2002;112:290-297.
32. Min JK, Castellanos J, Siegel R. New frontiers in CT angiography: physiologic assessment of coronary artery disease by multidetector CT. Heart. 2013;99:661-668.
33. Mor-Avi V, Lang RM, Badano LP, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications. Endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr. 2011;24:277-313.
34. Moreno PR, Purushothaman KR, Fuster V, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation. 2004;110:2032-2038.
35. Nakata T, Nakajima K, Yamashina S, et al. A pooled analysis of multicenter cohort studies of I-123-mIBG cardiac sympathetic innervation imaging for assessment of long-term prognosis in chronic heart failure. JACC Cardiovasc Imaging. 2013;6:772-784.
36. Nakauchi Y, Iwanaga Y, Ikuta S.et al. Quantitative myocardial perfusion analysis using multi-row detector CT in acute myocardial infarction. Heart. 2012;98:566-572.
37. Nakazato R, Park HB, Berman DS, et al. Noninvasive fractional flow reserve derived from computed tomography angiography for coronary lesions of intermediate stenosis severity. Results from the DeFACTO study. Circ Cardiovasc Imaging. 2013;6:881-889.
38. Panel NCEPE. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
39. Phelan D, Collier P, Thavendiranathan P, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography in both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98:1442-1448.
40. Pijls NH, Fearon WF, Tonio PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol. 2010;56:177-184.
41. Schaap J, de Groot JAH, Nieman K, et al. Hybrid myocardial perfusion SPECT/CT coronary angiography and invasive coronary angiography in patients with stable angina pectoris lead to similar treatment decisions. Heart. 2013;99:188-194.
42. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283-1291.
43. Stanton T, Leano R, Marwick TH. Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging. 2009;2:356-364.
44. Su HM, Lin TH, Hsu PC, et al. Global left ventricular longitudinal systolic strain as a major predictor of cardiovascular events in patients with atrial fibrillation. Heart. 2013;99:1588-1596.
45. Sun JP, Stewart WJ, Yang XS, et al. Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Am J Cardiol. 2009;103:411-415.
46. Tian J, Hou J, Xing L, et al. Significance of intraplaque neovascularization for vulnerability: optical coherence tomography study. Heart. 2012;98:1504-1509.
47. Uemura S, Ishigami KI, Soeda T, et al. Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques. Eur Heart J. 2012;33:78-85.
48. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thormb Vasc Biol. 2005;25:2054-2061.
49. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920-2925.
50. Yiu KH, de Gaaf FR, Schuijf JD, et al. Age- and gender-specific differences in the prognostic value of CT coronary angiography. Heart. 2012;98:232-237.
51. Zakeri R, Borlaug BA, McNuty SE, et al. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction. A RELAX trial ancillary study. Circ Heart Fail. 2014;7:123-130.